<DOC>
	<DOCNO>NCT02365779</DOCNO>
	<brief_summary>High-grade serous ovarian cancer threaten type gynaecological cancer important mortality due late diagnosis . However prognosis excellent early stage disease . Recently describe new serous carcinogenic sequence fallopian tube tubal precancerous lesion . Therefore identification early preinvasive lesion would great interest population hereditary predisposition ovarian cancer ( concept oncofertility ) general population ( determine whether bilateral salpingectomy perform hysterectomy benign disease ) . The optical biopsy develop validated detection early precancerous lesion ( Barrett 's oesophagus situ cancer bladder ) . The first objective study prospectively assess efficacy optical biopsy ( Cellvizio® ) study fallopian tube laparoscopy correlation histopathological immunohistochemical analysis endomicroscopy image interpretation . The second objective describe optical biopsy picture order state classification .</brief_summary>
	<brief_title>Optical Biopsy Fallopian Tube</brief_title>
	<detailed_description>Inclusion Criteria : - Woman age 18 year - All patient laparoscopic salpingectomy benign condition ( tubal ligation , hysterectomy ) , prophylactic condition ( BRCA mutation ) case pelvic cancer - Informed sign consent Exclusion Criteria : - Interview reveal disorder entail unacceptable risk postoperative complication : coagulation disorder , immune system disorder , evolutive disease , etc . - Pregnancy , ongoing plan study period - Allergy fluorescein - Previous allergy anaphylactic shock angiography - Allergic hypersensibility reaction - Severe asthma , chronic cardiac pulmonary disease - Restricted renal function - Patient beta-blockers treatment - Inability understand information provide - Not cover national health insurance scheme , prisoner administrative supervision</detailed_description>
	<criteria>Woman age 18 year All patient laparoscopic salpingectomy benign condition ( tubal ligation , hysterectomy ) , prophylactic condition ( BRCA mutation ) case pelvic cancer Informed signed consent Interview reveal disorder entail unacceptable risk postoperative complication : coagulation disorder , immune system disorder , evolutive disease , etc . Pregnancy , ongoing plan study period Allergy fluorescein Previous allergy anaphylactic shock angiography Allergic hypersensibility reaction Severe asthma , chronic cardiac pulmonary disease Restricted renal function Patient betablockers treatment Inability understand information provide Not cover national health insurance scheme , prisoner administrative supervision</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>salpingectomy</keyword>
	<keyword>optical biopsy</keyword>
	<keyword>Cellvizio®</keyword>
</DOC>